Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 at the Baltimore Convention Center, Siemens Healthcare debuted new technologies designed to expand the capabilities and improve the productivity of molecular imaging. Symbia Evo, Siemens' new single-photon emission computed tomography (SPECT) system, boosts user productivity, providing facilities with more time to plan treatment schedules, personalize studies, serve additional patients and improve workflow efficiency.

ClearDATA announced the close of an over-subscribed $25 million Series C funding round with contributions from Heritage Group, HLM Venture Partners and Flare Capital Partners. The company also received contributions from existing investors Norwest Venture Partners, Merck Global Health Innovation Fund and Excel Venture Management. The investment will be used to maximize the cloud company's growth in the market for health information technology cloud computing, supporting its fourth consecutive year of 100+ percent year-over-year subscription revenue growth.

The nation’s top consumer, patient and labor advocates recently praised the proposed Stage 3 Meaningful Use rules, describing how they would help ensure health information technology (IT) meets the needs of patients and families.

Professional physician associations consider certain routine tests before elective surgery to be of low value and high cost, and have sought to discourage their utilization. Nonetheless, a new national study by researchers at NYU Langone Medical Center finds that despite these peer-reviewed recommendations, no significant changes have occurred over a 14-year period in the rates of several kinds of these pre-operative tests.